Metabolic signatures linked to macrophage polarization: from glucose metabolism to oxidative phosphorylation.
暂无分享,去创建一个
L. Boscá | S. Alemany | M. Mojena | P. Prieto | S. González-Ramos | M. Fernández-Velasco | P. Martı́n-Sanz | P. Martín-Sanz
[1] Z. Fayad,et al. HIF-1&agr; and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[2] Steffen Jung,et al. Macrophages: development and tissue specialization. , 2015, Annual review of immunology.
[3] Susan R. Quinn,et al. Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. , 2015, Cell metabolism.
[4] Haichao Wang,et al. PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis , 2014, Nature Communications.
[5] Zachary W. Dwyer,et al. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells. , 2014, Molecular cell.
[6] L. Boscá,et al. Involvement of monocytes/macrophages as key factors in the development and progression of cardiovascular diseases. , 2014, The Biochemical journal.
[7] V. Fuster,et al. 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis , 2014, Nature Medicine.
[8] P. Taylor,et al. Tissue-resident macrophages , 2013, Nature Immunology.
[9] Jie Li,et al. PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells , 2013, Cell.
[10] P. Carmeliet,et al. Role of PFKFB3-Driven Glycolysis in Vessel Sprouting , 2013, Cell.
[11] P. Libby,et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis , 2013, Nature Medicine.
[12] W. Sellers,et al. M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth , 2012, Proceedings of the National Academy of Sciences.
[13] Eyal Gottlieb,et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2 , 2012, Nature.
[14] Christian M. Metallo,et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis , 2012, Nature chemical biology.
[15] E. Gottlieb,et al. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer. , 2012, Trends in biochemical sciences.
[16] K. Venema,et al. Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects , 2012, European journal of clinical investigation.
[17] M. Cascante,et al. Relevance of the MEK/ERK Signaling Pathway in the Metabolism of Activated Macrophages: A Metabolomic Approach , 2012, The Journal of Immunology.
[18] P. Libby,et al. Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. , 2011, Journal of the American College of Cardiology.
[19] Peter Carmeliet,et al. Hypoxia and inflammation. , 2011, The New England journal of medicine.
[20] Wei-Shou Hu,et al. Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways. , 2010, Trends in biotechnology.
[21] Daniel Rico,et al. Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation , 2010, The Journal of Immunology.
[22] A. Mantovani,et al. Molecular pathways linking inflammation and cancer. , 2010, Current molecular medicine.
[23] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[24] C. Glass,et al. Macrophages, inflammation, and insulin resistance. , 2010, Annual review of physiology.
[25] L. Boscá,et al. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways , 2010, Cell Death and Differentiation.
[26] L. Pellerin,et al. Enhanced Cerebral Expression of MCT1 and MCT2 in a Rat Ischemia Model Occurs in Activated Microglial Cells , 2009, Journal of Cerebral Blood Flow and Metabolism.
[27] Vidya Subramanian,et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. , 2008, Cell metabolism.
[28] John O Trent,et al. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth , 2008, Molecular Cancer Therapeutics.
[29] S. Gordon. The macrophage: Past, present and future , 2007, European journal of immunology.
[30] V. Nizet,et al. Cutting Edge: Essential Role of Hypoxia Inducible Factor-1α in Development of Lipopolysaccharide-Induced Sepsis1 , 2007, The Journal of Immunology.
[31] Juan M. Vaquerizas,et al. Identification of conserved domains in the promoter regions of nitric oxide synthase 2: implications for the species-specific transcription and evolutionary differences , 2007, BMC Genomics.
[32] A. Lane,et al. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase , 2006, Oncogene.
[33] Alberto Mantovani,et al. Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.
[34] R. Bucala,et al. Phosphorylation of the 6-Phosphofructo-2-Kinase/Fructose 2,6-Bisphosphatase/PFKFB3 Family of Glycolytic Regulators in Human Cancer , 2005, Clinical Cancer Research.
[35] L. Boscá,et al. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. , 2005, Toxicology.
[36] J. L. Rosa,et al. 6-Phosphofructo-2-kinase (pfkfb3) Gene Promoter Contains Hypoxia-inducible Factor-1 Binding Sites Necessary for Transactivation in Response to Hypoxia* , 2004, Journal of Biological Chemistry.
[37] R. Sakakibara,et al. Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. , 2004, Journal of biochemistry.
[38] D. Vertommen,et al. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. , 2004, The Biochemical journal.
[39] N. Sang,et al. Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene , 2002, The Journal of Biological Chemistry.
[40] K. Uyeda,et al. Regulation of Energy Metabolism in Macrophages during Hypoxia , 2001, The Journal of Biological Chemistry.
[41] R. Gamelli,et al. EXPRESSION OF THE LACTATE TRANSPORTER MCT1 IN MACROPHAGES , 2000, Shock.
[42] P. Newsholme,et al. Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture. , 1989, The Biochemical journal.
[43] A. Sols,et al. Modulation of muscle phosphofructokinase at physiological concentration of enzyme. , 1985, The Journal of biological chemistry.
[44] Mitochondrial membrane-bound hexokinase of ascites tumor cells. Functional implications of lysine residues studied by modification with imidoesters. , 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[45] A. Sols,et al. Substrate specificity of brain hexokinase. , 1954, The Journal of biological chemistry.